Gastroenterology Market, By Drug Type (Biologics/Biosimilars, Antacids, Laxatives, Antidiarrheal Agents, Antiemetics, Antiulcer Agents, Others), By Dosage Form (Oral, Parenteral, Others), By Disease Type (Inflammatory Bowel Diseases (IBD), Crohn\'s Disease, Ulcerative Colitis, Irritable Bowel Syndrome (IBS), Gastroesophageal Reflux Disease, Liver Diseases, Colorectal Cancer, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Sep 2024

Code : CMI7416

Pages :140

Formats :

Excel and PDF

Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Gastroenterology Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Rising geriatric population

Growing global geriatric population aged 65 years or older can drive the market growth. According to estimates, their number is expected to double by 2050. According to the data published by United Nations, 1 in 6 people in the world will be over age of 65 years by 2050. Aging is usually accompanied by declining organ functions and rising vulnerability of various age-related diseases. Digestive disorders are highly common among the elderly population due to a number of physiological changes that naturally occur with aging. Factors like reduced stomach acid secretion, reduced digestion and absorption functions of the gastrointestinal tract, reduced gastric motility and delay in bowel movement predispose the elderly to gastrointestinal problems. Common age-related GI issues include gastroesophageal reflux, constipation, incontinence and risks of colon cancer.

Elderly people also tend to have multiple co-morbidities and are on long term medication usage which escalates their susceptibility to drug-induced GI complications. Growing geriatric demographic worldwide has resulted in a massive patient pool requiring gastroenterology treatments. It boosts demand for digestive medications, diagnostic and monitoring services as well as endoscopy devices. Ageing population also leads to increase in gastrointestinal cancers incidence especially in developed nations with Japan, North America and Western Europe home to the largest aged population burden globally. This rising trend of geriatric population can drive the global gastroenterology market growth.

By Drug Type Insights (Revenue, USD Bn, 2019 - 2031)
- Biologics/Biosimilars
- Antacids
- Laxatives
- Antidiarrheal Agents
- Antiemetics
- Antiulcer Agents
- Others
By Dosage Form Insights (Revenue, USD Bn, 2019 - 2031)
- Oral
- Parenteral
- Others
By Disease Type Insights (Revenue, USD Bn, 2019 - 2031)
- Inflammatory Bowel Diseases (IBD)
- Crohn's Disease
- Ulcerative Colitis
- Irritable Bowel Syndrome (IBS)
- Gastroesophageal Reflux Disease (GERD)
- Liver Diseases
- Colorectal Cancer
- Others (Peptic Ulcers, etc.)
By Distribution Channel Insights (Revenue, USD Bn, 2019 - 2031)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC Countries
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - North Africa
  - Central Africa